Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
Top Cited Papers
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 362 (9377) , 7-13
- https://doi.org/10.1016/s0140-6736(03)13800-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Beta-blockade in heart failure: A comparison of carvedilol with metoprololJournal of the American College of Cardiology, 1999
- Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprololJournal of the American College of Cardiology, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivityJournal Of Hypertension, 1996
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975